Phaim Pharma is dedicated to developing potentially curative treatments for auto-immune diseases. The company is developing a range of novel therapeutic innovations including an exciting new therapy to treat and prevent diabetes as well as a predictive biomarker kit for first-degree relatives. The long-term goal is the broadening of our platform approach to other autoimmune diseases, such as psoriasis, through our active R & D programme. Our team is dedicated on improving lives of people with diabetes and we are a UK based company working with world-class companies to deliver life-changing therapies.